U.S. Life Sciences Stock News

In February 2026, Global Payments Inc. completed a transformative reshaping of its portfolio around merchant payments, pairing the Worldpay acquisition with the divestiture of its Issuer Solutions business and announcing a US$2.50 billion share repurchase program that includes an immediate US$550 million accelerated buyback. Alongside these moves, the company refreshed its leadership bench with a new independent director, Vivek Sankaran, and promoted long-time finance executive Jennifer...

RingCentral (RNG) shares have been in focus after a busy February, when the company reported full year 2025 earnings, initiated a quarterly dividend, expanded its buyback authorization, and outlined new 2026 revenue guidance. See our latest analysis for RingCentral. Those February announcements appear to have reset sentiment around RingCentral, with a 39.64% 30 day share price return and 30.99% year to date share price return pointing to building momentum despite a 5 year total shareholder...

Penguin Solutions (PENG) has drawn fresh attention after appointing Ian Colle as senior vice president and chief product officer, placing him in charge of product strategy for the company’s AI Factory Platform. See our latest analysis for Penguin Solutions. At a share price of US$20.05, Penguin Solutions has seen a 4.4% 30 day share price return and a 6.6% 1 year total shareholder return. This suggests recent momentum has picked up even though longer term gains remain modest. If the AI...

Flowco Holdings (NYSE:FLOC) announced it is acquiring Valiant Artificial Lift Solutions. The deal is intended to strengthen Flowco's artificial lift capabilities and broaden its customer reach. The transaction focuses on expanding Flowco's offerings within the artificial lift solutions sector. For you as an investor, this deal sits at the core of what Flowco Holdings does, supplying artificial lift solutions to energy producers. The artificial lift space has been seeing ongoing interest as...

Monster Beverage has overhauled its senior leadership, naming new CEOs for its Americas and EMEA regions and appointing a Chief Strategy Officer. The changes are intended to support the company’s growth plans across global markets and sharpen execution in key regions. The leadership update comes with Monster Beverage shares trading at $81.06 under ticker NasdaqGS:MNST. For investors watching NasdaqGS:MNST, the leadership reshuffle lands after a strong multi year share price run, with the...

Churchill Downs (NasdaqGS:CHDN) has opened Marshall Yards Racing & Gaming, its eighth historical horse racing entertainment venue in Kentucky. The new property adds gaming and entertainment capacity while supporting purse funding for associated racing meets. For investors tracking Churchill Downs, the opening of Marshall Yards comes at a time when the stock trades at $93.78, with a value score of 6. Over longer periods, returns have been weak, with the share price down 18.2% over the past...

In recent months, VeriSign, Inc. has highlighted the resilience of its .COM registry monopoly, reporting ongoing revenue growth, strong free cash flow, and substantial shareholder returns through US$859 million of 2025 buybacks alongside a 5.2% dividend increase. This combination of a legally protected core franchise and consistent cash returns underscores how reliant the business model is on stable, recurring domain revenues. Against this backdrop of robust cash generation and increased...

In late February 2026, the Centers for Medicare & Medicaid Services confirmed it will assign specific C-codes for Inspire Medical Systems’ Inspire V device in an upcoming outpatient coding update, resolving longstanding reimbursement uncertainties for its hypoglossal nerve stimulation therapy for obstructive sleep apnea. This coding clarification is important because it simplifies hospital and ambulatory surgery center billing, may improve payment predictability, and could make it easier for...

Par Pacific Holdings (NYSE:PARR) reported record refining throughput in 2025, including recovery from an earlier operational issue at its Wyoming refinery. The company recorded a substantial gain tied to an EPA small refinery exemption in 2025. Par Pacific launched the Hawaii Renewables joint venture and advanced plans for a renewable fuels facility in 2025. The company carried out a major share repurchase in 2025, highlighting a focus on shareholder returns. Par Pacific Holdings, the...

If you are wondering whether TFS Financial is offering fair value at today’s price, you are not alone. This article is designed to help you weigh what the current share price might be implying. The stock most recently closed at US$14.33, with returns of 0.8% over 7 days, 1.8% over 30 days, 5.6% year to date, 17.9% over 1 year, 31.8% over 3 years and a 2.6% decline over 5 years. Recent news around TFS Financial has focused on its position as a regional bank and its role in the broader US...

If you are wondering whether Amcor's recent share price moves still leave value on the table, you are not alone. This article is aimed at helping you weigh that up clearly. Over the short term, the stock has had a 4.8% decline over 7 days, but an 8.8% return over 30 days and a 14.5% return year to date, with a 0.7% return over 1 year, 2.1% over 3 years and 3.9% over 5 years. Taken together, these figures give a mixed picture of momentum and risk sentiment. This article was prompted to keep...

Ardagh Metal Packaging (AMBP) has given investors plenty to think about after reporting 2025 results that exceeded its own guidance, outlining 2026 adjusted EBITDA growth expectations, completing a US$1.3b green bond refinancing, and affirming a quarterly dividend. See our latest analysis for Ardagh Metal Packaging. The recent earnings beat, 2026 EBITDA guidance and US$1.3b green bond refinancing sit against a share price of US$4.85, with a 30 day share price return of 10.48% and a 1 year...

Event overview and immediate context Generate Biomedicines (GENB) recently drew investor attention after a single day move of about 3.8% and a year to date return of roughly a 23.9% decline, prompting closer scrutiny of its drug discovery model and early stage pipeline. See our latest analysis for Generate Biomedicines. For now, the 1 day share price return of about 3.8% and year to date share price return of roughly a 23.9% decline suggest sentiment has cooled, even as interest in its...

LCI Industries (NYSE:LCII) has signaled ongoing interest in acquisitions, highlighting a renewed focus on M&A within its core markets. The company referenced a history of completed deals and expressed intentions to build on recent M&A momentum. This more active approach to acquisitions could influence LCI Industries' growth path, competitive position and capital deployment priorities. For investors watching NYSE:LCII, the renewed emphasis on acquisitions comes as the shares trade at...

Empire State Realty OP (ESBA) just wrapped up FY 2025 with Q4 total revenue of US$199.7 million and basic EPS of US$0.13, while trailing twelve month revenue sits at US$768.3 million and EPS at US$0.27. Over the past few quarters, revenue has moved from US$197.6 million in Q4 2024 to US$199.7 million in Q4 2025, with quarterly EPS shifting from US$0.07 to US$0.13. This sets up a picture where investors will be weighing these earnings against a 9.5% net margin and the impact of a one off gain...

UroGen Pharma FY 2025 results set the stage for growth versus losses debate UroGen Pharma (URGN) closed out FY 2025 with Q4 revenue of US$37.8 million and a basic EPS loss of US$0.54, alongside a trailing twelve month loss of US$3.19 per share on US$109.8 million of revenue. The company has seen quarterly revenue move from US$24.6 million in Q4 2024 to US$37.8 million in Q4 2025. Over the same period, basic EPS ranged from a loss of US$1.05 in Q2 2025 to a loss of US$0.54 in the latest...

Interactive Brokers Group (NasdaqGS:IBKR) reports strong growth in client activity and trading volumes. The broker launches stablecoin funding for U.S. clients, allowing deposits in certain digital dollar tokens. The company highlights continued progress in brokerage technology and its inclusion in the S&P 500 Index. Interactive Brokers Group, trading at around $71.67, sits in a very different place than it did a few years ago, with a 1 year return of 43.0% and a 5 year return of 288.5%...

Immunome, Inc. recently presented at the TD Cowen 46th Annual Health Care Conference in Boston, updating investors on its oncology-focused pipeline and regulatory plans. A key highlight is the company’s push toward a New Drug Application for Varegacestat in desmoid tumors, alongside multiple upcoming solid tumor IND submissions and an FDA-cleared radioligand therapy trial. We’ll now examine how Immunome’s renewed oncology focus and advancing Varegacestat program might influence the company’s...

If you are wondering whether Bunge Global’s current share price lines up with its underlying worth, this article walks through the key numbers that matter for valuation. The stock recently closed at US$120.61, after a 0.6% decline over 7 days, a 5.9% gain over 30 days, and returns of 30.2% year to date, 73.1% over 1 year, 34.3% over 3 years, and 75.8% over 5 years. Recent coverage has focused on Bunge Global’s role in global agribusiness and food supply chains and how that positioning may...

Cullen/Frost Bankers (CFR) has drawn fresh attention after recent trading, with the share price closing at $140.21 and posting mixed short term returns while still showing gains over the past 3 months and year. See our latest analysis for Cullen/Frost Bankers. The recent 1 day share price return of 1.44% sits against a 7 day share price return of negative 1.35%. At the same time, the 90 day share price return of 13.93% and 1 year total shareholder return of 7.14% point to momentum that has...

Apogee Therapeutics reported a full-year net loss of US$255.84 million for 2025, with basic and diluted loss per share of US$4.22 as it continued to report no product revenue while investing heavily in its antibody pipeline. Alongside deeper losses, the company underscored upcoming clinical milestones for zumilokibart and other programs and filed a US$287.29 million shelf registration tied to an employee stock ownership plan, highlighting both capital needs and efforts to align employee...

NVR recently reported its fourth-quarter 2025 results, with earnings and Homebuilding revenue coming in ahead of consensus estimates despite weaker housing demand and affordability pressures. An interesting wrinkle is that, even with this earnings beat, analyst estimates for NVR have generally moved lower, pointing to a more cautious outlook on future performance. Next, we will examine how beating expectations amid softer housing demand shapes NVR's investment narrative for investors...

uniQure (QURE) has just wrapped up FY 2025 with fourth quarter revenue of US$5.6 million and a basic EPS loss of US$0.59, as net income excluding extra items came in at a loss of US$37.1 million. Over recent quarters, the company has seen revenue move between US$1.6 million and US$5.6 million while basic EPS ranged from a loss of US$0.59 to a loss of US$1.38. This gives investors a clear picture of a business that is still in heavy investment mode rather than focused on near term...

LXP Industrial Trust (LXP) has put fresh numbers in front of investors with its Q4 2025 investor presentation, spotlighting 97.1% portfolio occupancy and a new approximately 1 million square foot Phoenix development tied to strong industrial demand. See our latest analysis for LXP Industrial Trust. At a share price of $49.09, LXP Industrial Trust has seen a 15.53% 1 year total shareholder return, even though its year to date share price return is slightly negative and short term moves remain...